Thermo Fisher Scientific INC THER.../  US8835561023  /

LSE International Off-book
18/10/2024  20:04:28 Chg. +2.53 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
602.59USD +0.42% 251
Turnover: 150,610.41
-Bid Size: - -Ask Size: - 229.85 bill.USD 0.23% 38.77

Fundamentals

  FY 2023 Growth (1Y)
Per Share  
Earnings per Share: 15.52 USD -12.56%
EPS Diluted: 15.45 USD -12.37%
Revenues per Share: 112.39 USD -3.55%
Book Value per Share: 122.53 USD 7.26%
Cash Flow per Share: 22.04 USD -7.18%
Dividend per Share: 1.40 USD 16.67%
Total in mill.  
Revenues: 42,857.00 USD -4.58%
Net Income: 5,995.00 USD -13.74%
Operating Cash Flow: 8,406.00 USD -
Cash and Cash Equivalents: 8,077.00 USD -

Valuation Ratios

  Current Latest FY*
P/E Ratio: 38.77 34.20
P/S Ratio: 5.35 4.72
P/BV ratio: 4.91 4.33
P/CF Ratio: 27.29 24.08
PEG: -3.09 -2.72
Earnings Yield: 2.58% 2.92%
Dividend Yield: 0.23% 0.26%
Market Capitalization  
Market Capitalization: 229.85 bill. USD 202.4 bill. USD
Free Float Market Cap.: - USD - USD
Market Cap. / Employee: - USD - USD
Shares Outstanding: 382 mill.  
 

Profitability

Gross Profit Margin: -
EBIT Margin: 16.00%
Net Profit Margin: 13.99%
Return on Equity: 12.83%
Return on Assets: 6.07%

Financial Strength

Liquidity I / Cash Ratio: 0.58%
Liquidity II / Quick Ratio: 1.16%
Liquidity III / Current Ratio: 1.75%
Debt / Equity Ratio: 0.75%
Dynam. Debt / Equity Ratio: 618.63%

Efficiency

Employees: -
Personal Expenses / Employee: - USD
Revenues / Employee: - USD
Net Income / Employee: - USD
Total Assets / Employee: - USD
 
* Fiscal Year End: 31/12/2023
Accounting Standard: US GAAP
Currency: USD